Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

被引:126
作者
Sugarbaker, Paul H. [1 ]
Ryan, David P. [2 ,3 ]
机构
[1] Washington Canc Inst, Washington, DC USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
关键词
INTRAPERITONEAL CHEMOTHERAPY; SYSTEMIC CHEMOTHERAPY; OVARIAN-CANCER; HEPATIC RESECTION; RANDOMIZED-TRIAL; CARCINOMATOSIS; SURVIVAL; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN;
D O I
10.1016/S1470-2045(12)70210-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peritoneal carcinomatosis is a common presentation in patients with metastatic colorectal cancer and the overall survival is poor. In most patients, the disease remains limited to the peritoneal cavity. Therefore, investigators have applied cytoreductive surgery and hyperthermic perioperative chemotherapy as the standard approach for selected patients with peritoneal metastases from colorectal cancer. Overall, very promising long-term survival has been shown in a subset of patients with a limited extent of peritoneal disease before treatment. Whether randomised, controlled trials are needed to definitively show the magnitude of benefit, if any, of this approach is an important question. This Debate outlines the arguments on each side of this issue.
引用
收藏
页码:E362 / E369
页数:8
相关论文
共 45 条
[1]   A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats [J].
Aarts, F. ;
Hendriks, T. ;
Boerman, O. C. ;
Koppe, M. J. ;
Oyen, W. J. G. ;
Bleichrodt, R. P. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (11) :3274-3282
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]  
CAVALIER.R, 1967, CANCER-AM CANCER SOC, V20, P1351, DOI 10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO
[4]  
2-#
[5]   Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality [J].
Chua, Terence C. ;
Yan, Tristan D. ;
Saxena, Akshat ;
Morris, David L. .
ANNALS OF SURGERY, 2009, 249 (06) :900-907
[6]   Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer [J].
da Silva, Rodrigo Gomes ;
Sugarbaker, Paul H. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (06) :878-886
[7]  
DEDRICK RL, 1978, CANCER TREAT REP, V62, P1
[8]   Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: Results from intergroup N9741 [J].
Dy, Grace K. ;
Krook, James E. ;
Green, Erin M. ;
Sargent, Daniel J. ;
Delaunoit, Thierry ;
Morton, Roscoe F. ;
Fuchs, Charles S. ;
Ramanathan, Ramesh K. ;
Williamson, Stephen K. ;
Findlay, Brian P. ;
Pockaj, Barbara A. ;
Sticca, Robert P. ;
Alberts, Steven R. ;
Pitot, Henry C. ;
Goldberg, Richard M. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) :3469-3474
[9]   Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144 [J].
Dy, Grace K. ;
Hobday, Timothy J. ;
Nelson, Garth ;
Windschitl, Harold E. ;
O'Connell, Michael J. ;
Alberts, Steven R. ;
Goldberg, Richard M. ;
Nikcevich, Daniel A. ;
Sargent, Daniel J. .
CLINICAL COLORECTAL CANCER, 2009, 8 (02) :88-93
[10]   Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis [J].
Elias, Dominique ;
Goere, Diane ;
Di Pietrantonio, Daniela ;
Boige, Valerie ;
Malka, David ;
Kohneh-Shahri, Niaz ;
Dromain, Clarisse ;
Ducreux, Michel .
ANNALS OF SURGERY, 2008, 247 (03) :445-450